Author: Nebraska. Supreme Court
Publisher:
ISBN:
Category : Court rules
Languages : en
Pages : 932
Book Description
"Rules of the supreme court. In force February 1, 1914": v. 94, p. vii-xx.
Reports of Cases in the Supreme Court of Nebraska
Author: Nebraska. Supreme Court
Publisher:
ISBN:
Category : Court rules
Languages : en
Pages : 932
Book Description
"Rules of the supreme court. In force February 1, 1914": v. 94, p. vii-xx.
Publisher:
ISBN:
Category : Court rules
Languages : en
Pages : 932
Book Description
"Rules of the supreme court. In force February 1, 1914": v. 94, p. vii-xx.
Managing Wild Pigs
Author: Benjamin Corey West
Publisher:
ISBN: 9780974241517
Category : Feral swine
Languages : en
Pages : 55
Book Description
Publisher:
ISBN: 9780974241517
Category : Feral swine
Languages : en
Pages : 55
Book Description
Code of Federal Regulations
Author:
Publisher:
ISBN:
Category : Code of federal regulations
Languages : en
Pages : 120
Book Description
Publisher:
ISBN:
Category : Code of federal regulations
Languages : en
Pages : 120
Book Description
Veterinary Accreditation
Author:
Publisher:
ISBN:
Category : Accreditation (Education)
Languages : en
Pages : 214
Book Description
Publisher:
ISBN:
Category : Accreditation (Education)
Languages : en
Pages : 214
Book Description
Ecology, Conservation and Management of Wild Pigs and Peccaries
Author: Mario Melletti
Publisher: Cambridge University Press
ISBN: 1316947173
Category : Nature
Languages : en
Pages : 1417
Book Description
Wild pigs inhabit vast areas in Europe, Southern Asia and Africa, and have been introduced in North and South America, while feral pigs are widespread in Australia and New Zealand. Many wild pig species are threatened with extinction, but Eurasian wild boar populations, however, are increasing in many regions. Covering all wild pig and peccary species, the Suidae and Tayassuidae families, this comprehensive review presents new information about the evolution, taxonomy and domestication of wild pigs and peccaries alongside novel case studies on conservation activities and management. One hundred leading experts from twenty five countries synthesise understanding of this group of species; discussing current research, and gaps in the knowledge of researchers, conservation biologists, zoologists, wildlife managers and students. This beautifully illustrated reference includes the long history of interactions between wild pigs and humans, the benefits some species have brought us and their role and impact on natural ecosystems.
Publisher: Cambridge University Press
ISBN: 1316947173
Category : Nature
Languages : en
Pages : 1417
Book Description
Wild pigs inhabit vast areas in Europe, Southern Asia and Africa, and have been introduced in North and South America, while feral pigs are widespread in Australia and New Zealand. Many wild pig species are threatened with extinction, but Eurasian wild boar populations, however, are increasing in many regions. Covering all wild pig and peccary species, the Suidae and Tayassuidae families, this comprehensive review presents new information about the evolution, taxonomy and domestication of wild pigs and peccaries alongside novel case studies on conservation activities and management. One hundred leading experts from twenty five countries synthesise understanding of this group of species; discussing current research, and gaps in the knowledge of researchers, conservation biologists, zoologists, wildlife managers and students. This beautifully illustrated reference includes the long history of interactions between wild pigs and humans, the benefits some species have brought us and their role and impact on natural ecosystems.
The Necropsy Book
Author: John McKain King
Publisher:
ISBN: 9781427643353
Category : Veterinary autopsy
Languages : en
Pages : 251
Book Description
Publisher:
ISBN: 9781427643353
Category : Veterinary autopsy
Languages : en
Pages : 251
Book Description
Smallholder Dairying in the Tropics
Author: Lindsay Falvey
Publisher: ILRI (aka ILCA and ILRAD)
ISBN: 9780734014320
Category : Agricultural systems
Languages : en
Pages : 466
Book Description
Publisher: ILRI (aka ILCA and ILRAD)
ISBN: 9780734014320
Category : Agricultural systems
Languages : en
Pages : 466
Book Description
Report to the State Board of Agriculture
Author: Rhode Island. State nursery inspector
Publisher:
ISBN:
Category : Beneficial insects
Languages : en
Pages : 230
Book Description
Publisher:
ISBN:
Category : Beneficial insects
Languages : en
Pages : 230
Book Description
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Author: John Geigert
Publisher: Springer
ISBN: 3030137546
Category : Medical
Languages : en
Pages : 446
Book Description
Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the innovators and biosimilars); but now, an increasing awareness of the importance of gene therapy and genetically engineered cellular medicinal products. These biopharmaceuticals are being developed by many companies whose Chemistry, Manufacturing & Control (CMC) teams have varying degrees of familiarity or experience with the CMC strategy and regulatory compliance requirements for these challenging products. Companies clearly plan out the strategy for their clinical study plans, but frequently, the development of a strategy for CMC is an afterthought. Coupled with the complexity of the biopharmaceutical manufacturing processes and products, and this can be a recipe for disaster. The third edition of this book provides insights and practical guidance for the CMC teams to develop an acceptable cost-effective, risk-based CMC regulatory compliance strategy for all biopharmaceuticals (recombinant proteins, monoclonal antibodies, genetically engineered viruses and genetically engineered human cells) from early clinical stage development through market approval. The third edition of this book provides added coverage for the biosimilars, antibody drug conjugates (ADCs), bispecific antibodies, genetically engineered viruses, and genetically engineered cells. This third edition of the book also addresses the heightened pressure on CMC regulatory compliance timelines due to the introduction of expedited clinical pathways moving the clinical development closer to a seamless phase process (e.g., FDA Breakthrough Therapy designation, CBER Regenerative Medicine Advanced Therapy (RMAT) designation, EMA Priority Medicines (PRIME) designation). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals is essential, practical information for all pharmaceutical development scientists, Manufacturing and Quality Unit staff, Regulatory Affairs personnel, and senior management involved in the manufacture of biopharmaceuticals.
Publisher: Springer
ISBN: 3030137546
Category : Medical
Languages : en
Pages : 446
Book Description
Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the innovators and biosimilars); but now, an increasing awareness of the importance of gene therapy and genetically engineered cellular medicinal products. These biopharmaceuticals are being developed by many companies whose Chemistry, Manufacturing & Control (CMC) teams have varying degrees of familiarity or experience with the CMC strategy and regulatory compliance requirements for these challenging products. Companies clearly plan out the strategy for their clinical study plans, but frequently, the development of a strategy for CMC is an afterthought. Coupled with the complexity of the biopharmaceutical manufacturing processes and products, and this can be a recipe for disaster. The third edition of this book provides insights and practical guidance for the CMC teams to develop an acceptable cost-effective, risk-based CMC regulatory compliance strategy for all biopharmaceuticals (recombinant proteins, monoclonal antibodies, genetically engineered viruses and genetically engineered human cells) from early clinical stage development through market approval. The third edition of this book provides added coverage for the biosimilars, antibody drug conjugates (ADCs), bispecific antibodies, genetically engineered viruses, and genetically engineered cells. This third edition of the book also addresses the heightened pressure on CMC regulatory compliance timelines due to the introduction of expedited clinical pathways moving the clinical development closer to a seamless phase process (e.g., FDA Breakthrough Therapy designation, CBER Regenerative Medicine Advanced Therapy (RMAT) designation, EMA Priority Medicines (PRIME) designation). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals is essential, practical information for all pharmaceutical development scientists, Manufacturing and Quality Unit staff, Regulatory Affairs personnel, and senior management involved in the manufacture of biopharmaceuticals.
Medicines from Animal Cell Culture
Author: Glyn N. Stacey
Publisher: John Wiley & Sons
ISBN: 9780470723784
Category : Science
Languages : en
Pages : 696
Book Description
Medicines from Animal Cell Culture focuses on the use of animal cell culture, which has been used to produce human and veterinary vaccines, interferon, monoclonal antibodies and genetically engineered products such as tPA and erythropoietin. It also addresses the recent dramatic expansion in cell-based therapies, including the use of live cells for tissue regeneration and the culture of stem cells. Medicines from Animal Cell Culture: Provides comprehensive descriptions of methods for cell culture and nutrition as well as the technologies for the preservation and characterisation of both the cells and the derived products Describes the preparation of stem cells and others for use in cell-based therapies – an area of burgeoning research Includes experimental examples to indicate expected results Covers regulatory issues from the UK, the EU and the USA and reviews how these are developing around the world Addresses the key issues of standardisation and validation with chapters on GLP and GMP for cell culture processes Delivering insight into the exciting world of biological medicines and directions for further investigation into specific topics, Medicines from Animal Cell Culture is an essential resource for researchers and technicians at all levels using cell culture within the pharmaceutical, biotechnology and biomedical industries. It is of value to laboratory managers in these industries and to all those interested in this topic alike.
Publisher: John Wiley & Sons
ISBN: 9780470723784
Category : Science
Languages : en
Pages : 696
Book Description
Medicines from Animal Cell Culture focuses on the use of animal cell culture, which has been used to produce human and veterinary vaccines, interferon, monoclonal antibodies and genetically engineered products such as tPA and erythropoietin. It also addresses the recent dramatic expansion in cell-based therapies, including the use of live cells for tissue regeneration and the culture of stem cells. Medicines from Animal Cell Culture: Provides comprehensive descriptions of methods for cell culture and nutrition as well as the technologies for the preservation and characterisation of both the cells and the derived products Describes the preparation of stem cells and others for use in cell-based therapies – an area of burgeoning research Includes experimental examples to indicate expected results Covers regulatory issues from the UK, the EU and the USA and reviews how these are developing around the world Addresses the key issues of standardisation and validation with chapters on GLP and GMP for cell culture processes Delivering insight into the exciting world of biological medicines and directions for further investigation into specific topics, Medicines from Animal Cell Culture is an essential resource for researchers and technicians at all levels using cell culture within the pharmaceutical, biotechnology and biomedical industries. It is of value to laboratory managers in these industries and to all those interested in this topic alike.